|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

*
Section of Pulmonary and Critical Care Medicine, Department of Internal Medicine, and
Department of Pathology, Yale University School of Medicine, New Haven, CT 06520; and Pathology and Laboratory Medicine Service, Veterans Administration-Connecticut Health Care System, West Haven, CT 06516
Chronic Th2-dominated inflammation and exaggerated IL-6 production
are characteristic features of the asthmatic airway. To understand the
processes that are responsible for the chronicity of this response and
the role(s) of IL-6 in the regulation of airway Th2 inflammation, we
compared the responses induced by OVA in sensitized wild-type mice,
IL-6 deficient (-/-) mice, and transgenic mice in which IL-6 was
overexpressed in the airway (CC10-IL-6 mice). When compared with
wild-type mice, IL-6-/- mice manifest exaggerated
inflammation and eosinophilia, increased levels of IL-4, IL-5, and
IL-13 protein and mRNA, exaggerated levels of eotaxin, JE/monocyte
chemoattractant protein-1, macrophage inflammatory protein-1
and -2,
and mRNA, increased bronchoalveolar lavage (BAL) TGF-ß1,
and exaggerated airway responses to aerosolized methacholine. In
contrast, CC10-IL-6 mice, on both C57BL/6 and BALB/c backgrounds,
manifest diminished inflammation and eosinophilia, decreased levels of
IL-4, IL-5, and IL-13 protein and mRNA, and decreased levels of
bronchoalveolar lavage TGF-ß1. IL-6 also decreased the
expression of endothelial VCAM-1 and airway responsiveness to
methacholine in these animals. These alterations in the
IL-6-/- and CC10-IL-6 mice were not associated with
significant decreases or increases in the levels of IFN-
,
respectively. These studies demonstrate that endogenous and exogenous
IL-6 inhibit aeroallergen-induced Th2 inflammation and that this
inhibition is not mediated by regulatory effects of IFN-
. IL-6 may
be an important anti-inflammatory, counterregulatory, and healing
cytokine in the airway.
This article has been cited by other articles:
![]() |
M. Baroffio, E. Crimi, and V. Brusasco Review: Airway smooth muscle as a model for new investigative drugs in asthma Therapeutic Advances in Respiratory Disease, June 1, 2008; 2(3): 129 - 139. [Abstract] [PDF] |
||||
![]() |
A. J. Ammit, L. M. Moir, B. G. Oliver, J. M. Hughes, H. Alkhouri, Q. Ge, J. K. Burgess, J. L. Black, and M. Roth Effect of IL-6 trans-signaling on the pro-remodeling phenotype of airway smooth muscle Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L199 - L206. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rose-John, J. Scheller, G. Elson, and S. A. Jones Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer J. Leukoc. Biol., August 1, 2006; 80(2): 227 - 236. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ferrari, A. la Sala, E. Panther, J. Norgauer, F. Di Virgilio, and M. Idzko Activation of human eosinophils via P2 receptors: novel findings and future perspectives J. Leukoc. Biol., January 1, 2006; 79(1): 7 - 15. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Jones Directing Transition from Innate to Acquired Immunity: Defining a Role for IL-6 J. Immunol., September 15, 2005; 175(6): 3463 - 3468. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yang, J. Ochando, A. Yopp, J. S. Bromberg, and Y. Ding IL-6 Plays a Unique Role in Initiating c-Maf Expression during Early Stage of CD4 T Cell Activation J. Immunol., March 1, 2005; 174(5): 2720 - 2729. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Johnston, I. N. Schwartzman, L. Flynt, and S. A. Shore Role of interleukin-6 in murine airway responses to ozone Am J Physiol Lung Cell Mol Physiol, February 1, 2005; 288(2): L390 - L397. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Panettieri Jr. Effects of Corticosteroids on Structural Cells in Asthma and Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2004; 1(3): 231 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Land and F. Darakhshan Thymulin evokes IL-6-C/EBP{beta} regenerative repair and TNF-{alpha} silencing during endotoxin exposure in fetal lung explants Am J Physiol Lung Cell Mol Physiol, March 1, 2004; 286(3): L473 - L487. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Ikeda, M. Miller, J. Nayar, L. Walker, J. Y. Cho, K. McElwain, S. McElwain, E. Raz, and D. H. Broide Accumulation of Peribronchial Mast Cells in a Mouse Model of Ovalbumin Allergen Induced Chronic Airway Inflammation: Modulation by Immunostimulatory DNA Sequences J. Immunol., November 1, 2003; 171(9): 4860 - 4867. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Pavelko, C. L. Howe, K. M. Drescher, J. D. Gamez, A. J. Johnson, T. Wei, R. M. Ransohoff, and M. Rodriguez Interleukin-6 Protects Anterior Horn Neurons from Lethal Virus-Induced Injury J. Neurosci., January 15, 2003; 23(2): 481 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Ammit, A. L. Lazaar, C. Irani, G. M. O'Neill, N. D. Gordon, Y. Amrani, R. B. Penn, and R. A. Panettieri Jr. Tumor Necrosis Factor-alpha -Induced Secretion of RANTES and Interleukin-6 from Human Airway Smooth Muscle Cells . Modulation by Glucocorticoids and beta -Agonists Am. J. Respir. Cell Mol. Biol., April 1, 2002; 26(4): 465 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. M. Boudreau, R. Garduno, and T.-J. Lin Protein Phosphatase 2A and Protein Kinase Calpha Are Physically Associated and Are Involved in Pseudomonas aeruginosa-induced Interleukin 6 Production by Mast Cells J. Biol. Chem., February 8, 2002; 277(7): 5322 - 5329. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Titus, G. K. DeKrey, R. V. Morris, and M. B. P. Soares Interleukin-6 Deficiency Influences Cytokine Expression in Susceptible BALB Mice Infected with Leishmania major but Does Not Alter the Outcome of Disease Infect. Immun., August 1, 2001; 69(8): 5189 - 5192. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Ford, D. Rennick, D. D. Donaldson, R. Venkayya, C. McArthur, E. Hansell, V. P. Kurup, M. Warnock, and G. Grunig IL-13 and IFN-{gamma}: Interactions in Lung Inflammation J. Immunol., August 1, 2001; 167(3): 1769 - 1777. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |